Key result
Infliximab increases MAP and stroke work versus saline after resuscitation in swine.
Why the study?
Left ventricular dysfunction contributes to early death after cardiopulmonary resuscitation, and tumor necrosis factor-alpha, a proinflammatory cytokine known to decrease myocardial function, increases after resuscitation. This study tested whether blocking tumor necrosis factor-alpha with infliximab would prevent or minimize postresuscitation cardiac dysfunction.
Does infliximab improve postresuscitation cardiac dysfunction in a swine model of cardiac arrest?
RCT (n=28)
Randomized
No
Does infliximab improve postresuscitation cardiac dysfunction in a swine model of cardiac arrest?
Infliximab administration immediately after resuscitation from cardiac arrest attenuates early myocardial dysfunction in a swine model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for infliximab after swine cardiac arrest; leaves open translation to human resuscitation.
Objective:Left ventricular dysfunction after successful cardiopulmonary resuscitation contributes to early death after resuscitation. Proinflammatory cytokines are known to decrease myocardial function, and tumor necrosis factor- has been shown to increase after successful resuscitation. We hypothesized that blocking the effects of tumor necrosis factor- with infliximab would prevent or minimize postresuscitation cardiac dysfunction. Design:Randomized, placebo-controlled comparative study. Setting:Large animal research laboratory. Subjects:Twenty-eight anesthetized and instrumented domestic male swine (Yorkshire and Yorkshire/Hampshire mix; weight, 35-45 kg). Interventions:Infusion of infliximab (5 mg/kg) or normal saline after resuscitation from ventricular fibrillation cardiac arrest. Measurements and Main Results:Hemodynamic variables, indices of left ventricular function, and tumor necrosis factor- were measured before and after 8 mins of cardiac arrest during the early postresuscitation period (3 hrs). Within 5 mins of restoration of spontaneous circulation, 14 animals received infliximab, 5 mg/kg, infused over 30 mins. Fourteen animals received an infusion of normal saline. Inotropes and vasopressors were not administered to either group after resuscitation. Tumor necrosis factor- increased after restoration of circulation and remained elevated throughout the observation period. Differences between groups were not significant. Interleukin-1 concentration did not change significantly during the observation period in either study group. Mean arterial pressure and stroke work were significantly greater in the infliximab group within 30 mins of resuscitation, and these differences were sustained throughout the 3-hr postresuscitation period. The effect of tumor necrosis factor- blockade was evident only in animals with a significant increase (doubling) in plasma tumor necrosis factor- at 30 mins after arrest. Conclusion:Tumor necrosis factor- plays a role in cardiac dysfunction after arrest and infliximab may attenuate or prevent postresuscitation myocardial dysfunction when administered immediately after resuscitation.
No takes yet. Share an insight, caveat, or question.
Niemann et al. (2010) conducted an RCT in Ventricular fibrillation cardiac arrest and postresuscitation myocardial dysfunction (n=28). Infliximab vs. Normal saline was evaluated on Hemodynamic variables (mean arterial pressure) and indices of left ventricular function (stroke work). Infliximab increased mean arterial pressure and stroke work vs saline within 30 mins of resuscitation in 28 swine, sustained over 3 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: